Asymmetry Capital Management as of Sept. 30, 2018
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 35 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ptc Therapeutics I (PTCT) | 7.5 | $8.1M | 173k | 47.00 | |
| Insmed (INSM) | 6.7 | $7.3M | 360k | 20.22 | |
| Portola Pharmaceuticals | 6.2 | $6.7M | 252k | 26.63 | |
| Acadia Healthcare (ACHC) | 6.1 | $6.6M | 187k | 35.20 | |
| DaVita (DVA) | 4.9 | $5.3M | 74k | 71.63 | |
| Aerie Pharmaceuticals | 4.2 | $4.5M | 73k | 61.55 | |
| Amicus Therapeutics (FOLD) | 4.0 | $4.3M | 358k | 12.09 | |
| UnitedHealth (UNH) | 3.8 | $4.1M | 15k | 266.03 | |
| Global Blood Therapeutics In | 3.6 | $3.9M | 103k | 38.00 | |
| Jazz Pharmaceuticals (JAZZ) | 3.4 | $3.7M | 22k | 168.13 | |
| Centene Corporation (CNC) | 3.3 | $3.6M | 25k | 144.80 | |
| Incyte Corporation (INCY) | 3.1 | $3.4M | 49k | 69.08 | |
| Anaptysbio Inc Common (ANAB) | 3.1 | $3.3M | 33k | 99.76 | |
| Pfizer (PFE) | 2.8 | $3.0M | 68k | 44.06 | |
| Natera (NTRA) | 2.8 | $3.0M | 125k | 23.94 | |
| Neurocrine Biosciences (NBIX) | 2.6 | $2.8M | 23k | 122.94 | |
| CVS Caremark Corporation (CVS) | 2.6 | $2.8M | 36k | 78.73 | |
| OraSure Technologies (OSUR) | 2.6 | $2.8M | 180k | 15.45 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.2 | $2.4M | 13k | 192.73 | |
| Sarepta Therapeutics (SRPT) | 2.2 | $2.3M | 15k | 161.50 | |
| Acceleron Pharma | 2.1 | $2.3M | 40k | 57.23 | |
| Nucana Plc american depositary shares (NCNA) | 2.0 | $2.2M | 87k | 24.92 | |
| Viewray (VRAYQ) | 1.9 | $2.1M | 224k | 9.36 | |
| Penumbra (PEN) | 1.8 | $2.0M | 13k | 149.69 | |
| Ionis Pharmaceuticals (IONS) | 1.8 | $1.9M | 37k | 51.59 | |
| Urovant Sciences | 1.8 | $1.9M | 159k | 12.00 | |
| Nevro (NVRO) | 1.6 | $1.8M | 31k | 57.01 | |
| Heron Therapeutics (HRTX) | 1.6 | $1.8M | 56k | 31.66 | |
| Invitae (NVTAQ) | 1.6 | $1.8M | 105k | 16.73 | |
| Endocyte | 1.6 | $1.7M | 96k | 17.76 | |
| Neuronetics (STIM) | 1.3 | $1.5M | 45k | 32.06 | |
| Verrica Pharmaceuticals (VRCA) | 1.1 | $1.2M | 77k | 16.25 | |
| Kadmon Hldgs | 1.0 | $1.1M | 323k | 3.34 | |
| DURECT Corporation | 0.7 | $757k | 688k | 1.10 | |
| Gritstone Oncology Ord (GRTS) | 0.3 | $285k | 20k | 14.25 |
